Alhashim Maryam, Anan Noushin, Tamal Mahbubunnabi, Altarrah Hibah, Alshaibani Sarah, Hill Robin
Radiology Department, College of Medicine, Imam Abdulrahman Bin Faisal University, King Faisal Ibn Abd Al Aziz Rd, Dammam 34212, Saudi Arabia.
Medical Imaging Services Center, King Fahad Specialist Hospital Dammam, Dammam 32253, Saudi Arabia.
BJR Open. 2024 Oct 8;6(1):tzae034. doi: 10.1093/bjro/tzae034. eCollection 2024 Jan.
Wilms tumour, a common paediatric cancer, is difficult to treat in low- and middle-income countries due to limited access to imaging. Artificial intelligence (AI) has been introduced for staging, detecting, and classifying tumours, aiding physicians in decision-making. However, challenges include algorithm accuracy, translation into conventional diagnosis, reproducibility, and reliability. As AI technology advances, radiomics, an AI tool, emerges to extract tumour morphology and stage information.
This review explores the application of radiomics in Wilms tumour management, including its potential in diagnosis, prognosis, and treatment. Additionally, it discusses the future prospects of AI in this field and potential directions for automation-aided Wilms tumour treatment.
The review analyses various research studies and articles on the use of radiomics in Wilms tumour management. This includes studies on automated deep learning-based classification, interobserver variability in histopathological analysis, and the application of AI in staging, detecting, and classifying Wilms tumours.
The review finds that radiomics offers several promising applications in Wilms tumour management, including improved diagnosis: it helps in classifying Wilms tumours from other paediatric kidney tumours, prognosis prediction: radiomic features can be used to predict both staging and response to preoperative chemotherapy, Treatment response assessment: Radiomics can be used to monitor the response of Wilms and to predict the feasibility of nephron-sparing surgery.
This review concludes that radiomics has the potential to significantly improve the diagnosis, prognosis, and treatment of Wilms tumours. Despite some challenges, such as the need for further research and validation, AI integration in Wilms tumour management offers promising opportunities for improved patient care.
This review provides a comprehensive overview of the potential applications of radiomics in Wilms tumour management and highlights the significant role AI can play in improving patient outcomes. It contributes to the growing body of knowledge on AI-assisted diagnosis and treatment of paediatric cancers.
肾母细胞瘤是一种常见的儿科癌症,由于在低收入和中等收入国家难以获得影像学检查,其治疗存在困难。人工智能(AI)已被用于肿瘤分期、检测和分类,辅助医生进行决策。然而,挑战包括算法准确性、转化为传统诊断、可重复性和可靠性。随着人工智能技术的进步,一种人工智能工具——放射组学出现,用于提取肿瘤形态和分期信息。
本综述探讨放射组学在肾母细胞瘤管理中的应用,包括其在诊断、预后和治疗方面的潜力。此外,还讨论了人工智能在该领域的未来前景以及自动化辅助肾母细胞瘤治疗的潜在方向。
本综述分析了关于放射组学在肾母细胞瘤管理中应用的各种研究和文章。这包括基于自动深度学习分类的研究、组织病理学分析中的观察者间变异性,以及人工智能在肾母细胞瘤分期、检测和分类中的应用。
该综述发现,放射组学在肾母细胞瘤管理中具有几个有前景的应用,包括改善诊断:它有助于将肾母细胞瘤与其他儿科肾脏肿瘤区分开来;预后预测:放射组学特征可用于预测分期和术前化疗反应;治疗反应评估:放射组学可用于监测肾母细胞瘤的反应,并预测保留肾单位手术的可行性。
本综述得出结论,放射组学有潜力显著改善肾母细胞瘤的诊断、预后和治疗。尽管存在一些挑战,如需要进一步研究和验证,但将人工智能整合到肾母细胞瘤管理中为改善患者护理提供了有前景的机会。
本综述全面概述了放射组学在肾母细胞瘤管理中的潜在应用,并强调了人工智能在改善患者预后方面可发挥的重要作用。它为关于人工智能辅助儿科癌症诊断和治疗的知识体系不断发展做出了贡献。